Overview

Phrenic Nerve Infiltration in Fibromyalgia

Status:
Not yet recruiting
Trial end date:
2023-10-01
Target enrollment:
0
Participant gender:
Female
Summary
It is known that nociceptive afferences in visceral pain and visceral disorders increase sensitization in subjects suffering from fibromyalgia. These patients use to present visceral comorbidities. Those comorbidities include that of peridiaphragmatic organs, which are supplied by the phrenic nerve among other innervations. It is known that peridiaphragmatic organs trigger referred pain in the neck area, via the phrenic nerves. So, the phrenic nociceptive afferences can be contributing to enhance the state of sensitization in fibromyalgia. This study aims to analyze the ability of phrenic nerve infiltration to diminish sensitization in subjects suffering fibromyalgia, by means of a randomized controlled trial.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
University of Seville
Treatments:
Bupivacaine
Criteria
Inclusion Criteria:

- Women

- Over 18 and under 64 years old

- Diagnosis of Fibromyalgia

- Any peridiaphragmatic visceral disorder diagnosed by the respective specialist.

- That the subject agrees to participate in the project by signing the informed consent.

Exclusion Criteria:

- Other rheumatic diseases.

- Degenerative neurological disease.

- Major psychiatric disorder

- Cognitive deterioration

- Non-cooperative subject

- Any medical condition affecting sensory evaluation

- Contraindication to infiltration of the phrenic nerve.